Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma

Overview of attention for article published in Neuro-Oncology, May 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 47 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 921 followers.

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. https://t.co/2qYvT5V7tK #Neuralstemcells

#elderly #gliomas Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. https://t.co/nMktQgOci9

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.